Therapeutic Effect and Mechanism of Si-Miao-Yong-An-Tang on Thromboangiitis Obliterans Based on the Urine Metabolomics Approach

Overview

Journal Front Pharmacol

Date 2022 Mar 11

PMID 35273504

Authors

Hui-Yu Li

Hui Sun

Ai-Hua Zhang

Lu-Wen He

Shi Qiu

Jun-Ru Xue

Fangfang Wu

Xi-Jun Wang

Affiliations

Soon will be listed here.

Abstract

Si-Miao-Yong-An-Tang (SMYAT) is a classic prescription for the treatment of thromboangiitis obliterans (TAO). However, the effect and mechanism are still unclear. This experiment aims to evaluate the therapeutic effect and mechanism of SMYAT on sodium laurate solution induced thromboangiitis obliterans model rats using urine metabolomics. The therapeutic effect of SMYAT was evaluated by histopathology, hemorheology and other indexes. The urine metabolomic method, principal component analysis (PCA) and orthogonal partial least squares discriminant analysis (OPLS-DA) were used for clustering group and discriminant analysis to screen urine differential metabolic biomarkers, and explore new insight into pathophysiological mechanisms of SMYAT in the treatment of TAO. SMYAT has significant antithrombotic and anti-inflammatory effects, according to the results of urine metabolomic analysis, and regulate the metabolic profile of TAO rats, and its return profile is close to the state of control group. Through metabolomics technology, a total of 35 urine biomarkers of TAO model were characterized. Among them, SMYAT treatment can regulate 22 core biomarkers, such as normetanephrine and 4-pyridoxic acid. It is found that the therapeutic effect of SMYAT is closely related to the tyrosine metabolism, vitamin B6 metabolism and cysteine and methionine metabolism. It preliminarily explored the therapeutic mechanism of SMYAT, and provided a scientific basis for the application of SMYAT.

Citing Articles

Huangqi Guizhi Wuwu Decoction Improves Inflammatory Factor Levels in Chemotherapy-induced Peripheral Neuropathy by Regulating the Arachidonic Acid Metabolic Pathway.

Wang S, Du X, Yan G, Yang L, Sun H, Zhang X Curr Pharm Des. 2024; 30(34):2701-2717.

PMID: 39092641 DOI: 10.2174/0113816128308622240709102830.

Chinmedomics: a potent tool for the evaluation of traditional Chinese medicine efficacy and identification of its active components.

Wang M, Yin F, Kong L, Yang L, Sun H, Sun Y Chin Med. 2024; 19(1):47.

PMID: 38481256 PMC: 10935806. DOI: 10.1186/s13020-024-00917-x.

Exploring the potential mechanism of Simiao Yongan decoction in the treatment of diabetic peripheral vascular disease based on network pharmacology and molecular docking technology.

Cao F, Zhang Y, Zong Y, Feng X, Deng J, Wang Y Medicine (Baltimore). 2024; 102(52):e36762.

PMID: 38206683 PMC: 10754584. DOI: 10.1097/MD.0000000000036762.

Top 100 cited articles in the thromboangiitis obliterans: a bibliometric analysis and visualized study.

Liu Z, Ning W, Liang J, Zhang T, Yang Q, Zhang J Eur J Med Res. 2023; 28(1):551.

PMID: 38042838 PMC: 10693135. DOI: 10.1186/s40001-023-01540-6.

Pentadecapeptide BPC 157 as Therapy for Inferior Caval Vein Embolization: Recovery of Sodium Laurate-Post-Embolization Syndrome in Rats.

Smoday I, Krezic I, Kalogjera L, Vukovic V, Zizek H, Skoro M Pharmaceuticals (Basel). 2023; 16(10).

PMID: 37895979 PMC: 10610251. DOI: 10.3390/ph16101507.

References

Li M, Wang Y, Yang M, Hong F, Yang S . Risk Factors, Mechanisms and Treatments of Thromboangiitis Obliterans: An Overview of Recent Research. Curr Med Chem. 2019; 27(35):6057-6072. DOI: 10.2174/0929867326666190816233042. View

Liu X, Zhang A, Fang H, Li M, Song Q, Su J . Serum metabolomics strategy for understanding the therapeutic effects of Yin-Chen-Hao-Tang against Yanghuang syndrome. RSC Adv. 2022; 8(14):7403-7413. PMC: 9078382. DOI: 10.1039/c7ra11048k. View

Peng L, Li M, Xu Y, Zhang G, Yang C, Zhou Y . Effect of Si-Miao-Yong-An on the stability of atherosclerotic plaque in a diet-induced rabbit model. J Ethnopharmacol. 2012; 143(1):241-8. DOI: 10.1016/j.jep.2012.06.030. View

Zhang A, Sun H, Wu X, Wang X . Urine metabolomics. Clin Chim Acta. 2012; 414:65-9. DOI: 10.1016/j.cca.2012.08.016. View

Lains I, Gantner M, Murinello S, Lasky-Su J, Miller J, Friedlander M . Metabolomics in the study of retinal health and disease. Prog Retin Eye Res. 2018; 69:57-79. DOI: 10.1016/j.preteyeres.2018.11.002. View

Harpole M, Davis J, Espina V . Current state of the art for enhancing urine biomarker discovery. Expert Rev Proteomics. 2016; 13(6):609-26. PMC: 4978532. DOI: 10.1080/14789450.2016.1190651. View

Obeid R, Geisel J, Nix W . 4-Pyridoxic Acid/Pyridoxine Ratio in Patients with Type 2 Diabetes is Related to Global Cardiovascular Risk Scores. Diagnostics (Basel). 2019; 9(1). PMC: 6468858. DOI: 10.3390/diagnostics9010028. View

Zhang A, Sun H, Qiu S, Wang X . Advancing drug discovery and development from active constituents of yinchenhao tang, a famous traditional chinese medicine formula. Evid Based Complement Alternat Med. 2013; 2013:257909. PMC: 3804150. DOI: 10.1155/2013/257909. View

Klein-Weigel P, Volz T, Richter J . [Thromboangiitis obliterans (Buerger's disease): update 2015]. Dtsch Med Wochenschr. 2015; 140(20):1486-9. DOI: 10.1055/s-0041-106246. View

10.

Zhang A, Wang H, Sun H, Zhang Y, An N, Yan G . Metabolomics strategy reveals therapeutical assessment of limonin on nonbacterial prostatitis. Food Funct. 2015; 6(11):3540-9. DOI: 10.1039/c5fo00489f. View

11.

Zhao Y, Jiang Y, Chen Y, Zhang F, Zhang X, Zhu L . Dissection of mechanisms of Chinese medicinal formula Si-Miao-Yong-an decoction protects against cardiac hypertrophy and fibrosis in isoprenaline-induced heart failure. J Ethnopharmacol. 2019; 248:112050. DOI: 10.1016/j.jep.2019.112050. View

12.

Stanulovic M, Jeremic V, Leskovac V, Chaykin S . New pathway of conversion of pyridoxal to 4-pyridoxic acid. Enzyme. 1976; 21(4):357-69. DOI: 10.1159/000458879. View

13.

Qiu S, Zhang A, Guan Y, Sun H, Zhang T, Han Y . Functional metabolomics using UPLC-Q/TOF-MS combined with ingenuity pathway analysis as a promising strategy for evaluating the efficacy and discovering amino acid metabolism as a potential therapeutic mechanism-related target for geniposide against.... RSC Adv. 2022; 10(5):2677-2690. PMC: 9048633. DOI: 10.1039/c9ra09305b. View

14.

Zhang A, Sun H, Han Y, Yuan Y, Wang P, Song G . Exploratory urinary metabolic biomarkers and pathways using UPLC-Q-TOF-HDMS coupled with pattern recognition approach. Analyst. 2012; 137(18):4200-8. DOI: 10.1039/c2an35780a. View

15.

Qiu S, Zhang A, Zhang T, Sun H, Guan Y, Yan G . Dissect new mechanistic insights for geniposide efficacy on the hepatoprotection using multiomics approach. Oncotarget. 2018; 8(65):108760-108770. PMC: 5752478. DOI: 10.18632/oncotarget.21897. View

16.

Kalle S, Tanner R, Arund J, Tomson R, Luman M, Fridolin I . 4-Pyridoxic Acid in the Spent Dialysate: Contribution to Fluorescence and Optical Monitoring. PLoS One. 2016; 11(9):e0162346. PMC: 5012589. DOI: 10.1371/journal.pone.0162346. View

17.

Guo R, Luo X, Liu J, Liu L, Wang X, Lu H . Omics strategies decipher therapeutic discoveries of traditional Chinese medicine against different diseases at multiple layers molecular-level. Pharmacol Res. 2020; 152:104627. DOI: 10.1016/j.phrs.2020.104627. View

18.

Johnson C, Ivanisevic J, Siuzdak G . Metabolomics: beyond biomarkers and towards mechanisms. Nat Rev Mol Cell Biol. 2016; 17(7):451-9. PMC: 5729912. DOI: 10.1038/nrm.2016.25. View

19.

Desjars P, Pinaud M . [Norepinephrine in hyperkinetic septic shock: from a misunderstood process to justified rehabilitation]. Ann Fr Anesth Reanim. 1989; 8(1):1-3. DOI: 10.1016/s0750-7658(89)80134-0. View

20.

Khamis M, Adamko D, El-Aneed A . Mass spectrometric based approaches in urine metabolomics and biomarker discovery. Mass Spectrom Rev. 2015; 36(2):115-134. DOI: 10.1002/mas.21455. View